{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:45:20Z","timestamp":1793317520291,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"5","funder":[{"name":"Ministerial projects of the National Working Commission on Aging"},{"name":"The Four hundred project of 301"},{"name":"National Sciences Foundation of China"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,4,5]]},"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Thromboembolic events are the major factor affecting the prognosis of patients with chronic kidney disease (CKD). Haemostatic alterations are possible causes of these complications, but their roles remain poorly characterised. In the prospective observational study, we investigated the entire coagulation process in patients with CKD to elucidate the mechanisms of their high thromboembolic risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 95 patients with CKD and 20 healthy controls who met the inclusion criteria were consecutively recruited from September 2015 to March 2016. The platelet count, platelet aggregation, von Willebrand factor antigen (vWF:Ag), vWF ristocetin cofactor activity (vWF:RCo), fibrinogen, factor V (FV), FVII, FVIII, antithrombin III, protein C, protein S, D-dimer, standard coagulation tests and thromboelastography were measured in patients with CKD and controls. Associations between the estimated glomerular filtration rate (eGFR) and haemostatic biomarkers were tested using multivariable linear regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The adjusted and unadjusted levels of vWF:Ag, vWF:RCo, fibrinogen, FVII, FVIII and D-dimer were significantly higher in patients with CKD than that in the healthy controls, and were elevated with CKD progression. However, after adjustment for baseline differences, platelet aggregation and thromboelastography parameters showed no significant differences between patients with CKD and healthy controls. In the correlation analysis, vWF:Ag, vWF:RCo and FVIII were inversely associated with eGFR (r=\u22120.359, p&lt;0.001; r=\u22120.391, p&lt;0.001; r=\u22120.327, p&lt;0.001, respectively). During the 1-year of follow-up, one cardiovascular event occurred in patients with CKD 5 stage, whereas no thromboembolic event occurred in the CKD 3 and 4 and control groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients with CKD are characterised by endothelial dysfunction and increased coagulation, especially FVIII activity. The abnormal haemostatic profiles may contribute to the elevated risk of thrombotic events but further longer-term study with large samples is still required to more precisely determine the relationship between the elevation of procoagulant factors and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2016-014294","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T20:10:12Z","timestamp":1496434212000},"page":"e014294","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":129,"title":["Blood coagulation system in patients with chronic kidney disease: a prospective observational study"],"prefix":"10.1136","volume":"7","author":[{"given":"Meng-Jie","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri-bao","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-yu","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Di","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-mei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,6,1]]},"reference":[{"key":"2025121407431537000_7.5.e014294.1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09260913"},{"key":"2025121407431537000_7.5.e014294.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007030308"},{"key":"2025121407431537000_7.5.e014294.3","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.489807"},{"key":"2025121407431537000_7.5.e014294.4","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"2025121407431537000_7.5.e014294.5","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-12-0785"},{"key":"2025121407431537000_7.5.e014294.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2005.06.011"},{"key":"2025121407431537000_7.5.e014294.7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0272-6386(12)80136-3","article-title":"Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis","volume":"23","author":"Vaziri","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"2025121407431537000_7.5.e014294.8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121407431537000_7.5.e014294.9","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32799"},{"key":"2025121407431537000_7.5.e014294.10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0032-1327770","article-title":"The diagnosis of venous thromboembolism","volume":"38","author":"Hogg","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"2025121407431537000_7.5.e014294.11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1182\/blood.V93.2.564","article-title":"Fibrin-dependent platelet procoagulant activity requires GPIb receptors and von willebrand factor","volume":"93","author":"B\u00e9guin","year":"1999","journal-title":"Blood"},{"key":"2025121407431537000_7.5.e014294.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032804"},{"key":"2025121407431537000_7.5.e014294.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01317.x"},{"key":"2025121407431537000_7.5.e014294.14","first-page":"89","article-title":"Validity of plasma fibrinogen, D-dimer, and the von willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis","volume":"12","author":"Kirmizis","year":"2006","journal-title":"Med Sci Monit"},{"key":"2025121407431537000_7.5.e014294.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.10.044"},{"key":"2025121407431537000_7.5.e014294.16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21429"},{"key":"2025121407431537000_7.5.e014294.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02620.x"},{"key":"2025121407431537000_7.5.e014294.18","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2009.42"},{"key":"2025121407431537000_7.5.e014294.19","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0038-1646627","article-title":"Plasma D dimer: a useful marker of fibrin breakdown in renal failure","volume":"61","author":"Gordge","year":"1989","journal-title":"Thromb Haemost"},{"key":"2025121407431537000_7.5.e014294.20","first-page":"91","article-title":"Significance of urinary fibrin\/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases","volume":"44","author":"Shibata","year":"1995","journal-title":"Clin Nephrol"},{"key":"2025121407431537000_7.5.e014294.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03953.x"},{"key":"2025121407431537000_7.5.e014294.22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/s-0038-1653865","article-title":"Marked increase of activated factor VII in uremic patients","volume":"73","author":"Kario","year":"1995","journal-title":"Thromb Haemost"},{"key":"2025121407431537000_7.5.e014294.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(02)00857-X"},{"key":"2025121407431537000_7.5.e014294.24","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1681\/ASN.V1271549","article-title":"The microinflammatory state in Uremia: causes and potential consequences","volume":"12","author":"Kaysen","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2025121407431537000_7.5.e014294.25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cca.2014.05.013","article-title":"Why is everyone so excited about thromboelastrography (TEG)?","volume":"436","author":"Karon","year":"2014","journal-title":"Clin Chim Acta"},{"key":"2025121407431537000_7.5.e014294.26","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90091-0"},{"key":"2025121407431537000_7.5.e014294.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-8180(97)00097-4"},{"key":"2025121407431537000_7.5.e014294.28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-134-8-200104170-00007"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2016-014294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:43:26Z","timestamp":1765727006000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2016-014294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1136\/bmjopen-2016-014294"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2016-014294","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5]]}}}